Tag: Statins
Gender Disparities Seen in Care for Younger Patients With ASCVD
Women with premature atherosclerotic cardiovascular disease receive less optimal care than men
Statin Use Tied to Better COVID-19 Survival
Findings show 53 percent increased survival among patients using statins before hospitalization
ASA: Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk
Event rates for time to first fatal or nonfatal stroke significantly reduced for IPE versus placebo
No Effect of Low-Dose Atorvastatin Found for Muscle Symptoms
For participants reporting muscle symptoms when taking statins, no overall effect seen for atorvastatin 20 mg versus placebo
Risk for Rheumatoid Arthritis Reduced for Patients With T2DM
Reduced risk may be attributable to statin use; no significant association seen for glycemic control, metformin use on RA risk
Aspirin Overused, Statins Underused for CVD Prevention in Seniors
56.4 percent aged 75 years and older using statin for secondary cardiovascular event prevention; 45.3 percent taking aspirin for primary prevention
Statins May Protect Heart From Chemo for Early Breast Cancer
Risk for heart failure hospital presentations significantly lower in statin-exposed women treated with anthracyclines
Statin Use for Primary Prevention of CVD Lower for Sexual Minorities
Lesbian, gay, bisexual population less likely to use statins in analyses adjusted for covariates
MI, ASCVD Risk Higher in Older Adults With Elevated LDL-C
And LDL cholesterol-lowering therapies are effective for reducing cardiovascular events in older adults
Statins Tied to Lower In-Hospital COVID-19 Mortality Risk
For adults hospitalized in Spain with COVID-19, treatment with statins associated with lower COVID-19-related mortality
